(January 7, 2019, 1:24 PM EST) -- WASHINGTON, D.C. — The U.S. Supreme Court on Jan. 7 said it won’t review a Ninth Circuit U.S. Court of Appeals ruling that sent a whistleblower case against HIV drug maker Gilead Sciences Inc. back to a federal district court (Gilead Sciences, Inc. v. United States, ex rel. Jeffrey Campie, et al., No. 17-936, U.S. Sup.)....